How are Pulmonary Function Tests (PFTs) interpreted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Pulmonary Function Tests (PFTs)

Pulmonary Function Tests should be interpreted using a systematic approach that identifies specific ventilatory patterns (obstructive, restrictive, mixed, or normal) and grades severity based on standardized criteria from the European Respiratory Society and American Thoracic Society guidelines. 1, 2

Key Components of PFT Interpretation

1. Essential PFT Components

  • Complete PFTs should include:
    • Pre- and post-bronchodilator spirometry
    • Lung volumes
    • Diffusing capacity of the lung for carbon monoxide (DLCO) 2

2. Systematic Interpretation Algorithm

Step 1: Assess Quality of Testing

  • Evaluate technician performance and test reliability
  • Confirm acceptable maneuvers and reproducible tests 1

Step 2: Identify Ventilatory Pattern

  • Obstructive Pattern: FEV₁/FVC ratio < 0.7 or below LLN
  • Restrictive Pattern: TLC < 80% predicted or below LLN
  • Mixed Pattern: Features of both obstruction and restriction
  • Normal Pattern: All parameters within normal limits 1, 2

Step 3: Grade Severity

For Obstructive Defects (based on FEV₁ % predicted):

Severity FEV₁ (% predicted)
Mild >70% and <LLN
Moderate 60-69%
Moderately Severe 50-59%
Severe 35-49%
Very Severe <35%

For Restrictive Defects (based on TLC % predicted):

Severity TLC (% predicted)
Mild >70% and <LLN
Moderate 60-69%
Moderately Severe 50-59%
Severe <50%

For DLCO Impairment:

Severity DLCO (% predicted)
Mild >60% and <LLN
Moderate 40-60%
Severe <40%

Step 4: Evaluate Additional Parameters

  • Assess bronchodilator response (significant if FEV₁ increases >12% and >200 mL)
  • Evaluate flow-volume loop morphology for characteristic patterns
  • Consider DLCO in context of ventilatory pattern 1, 2

Clinical Correlation and Pattern Recognition

Obstructive Pattern

  • Characterized by decreased expiratory flow rates
  • Common in asthma, COPD, bronchiectasis
  • Evaluate bronchodilator response to differentiate between asthma (typically reversible) and COPD (typically less reversible) 2

Restrictive Pattern

  • Characterized by reduced lung volumes with normal or increased flow rates
  • Consider:
    • Parenchymal diseases (interstitial lung diseases)
    • Chest wall disorders
    • Neuromuscular weakness
    • Pleural diseases 1, 2

Mixed Pattern

  • Features of both obstruction and restriction
  • Common in advanced COPD with air trapping and reduced lung compliance 2

DLCO Interpretation

  • Normal spirometry with decreased DLCO: Consider pulmonary vascular disorders, early ILD, or early emphysema
  • Restriction with normal DLCO: Consider chest wall or neuromuscular disorders
  • Restriction with decreased DLCO: Suggests ILD
  • Obstruction with decreased DLCO: Suggests emphysema 1

Important Considerations

Reference Values

  • Select reference values from sources that used similar equipment and had a test population that included the age range, sex, and ethnic group of individuals being tested
  • Use the same source for all spirometric indices 1

Racial and Ethnic Considerations

  • Traditional reference equations may not adequately account for racial/ethnic differences
  • Consider social determinants of health and environmental factors that may affect lung function 1

Longitudinal Monitoring

  • Changes in FEV₁ >12% and >200 mL are generally significant
  • Year-to-year changes in FEV₁ should exceed 15% to be considered clinically meaningful
  • Multiple measurements over time are more reliable indicators of change than two isolated measurements 1, 2

Common Pitfalls to Avoid

  1. Relying solely on percent predicted values without considering LLN
  2. Failing to assess quality of testing and maneuvers
  3. Not adjusting DLCO for hemoglobin and carboxyhemoglobin levels
  4. Over-interpreting small changes in lung function parameters
  5. Not considering the clinical context when interpreting results 1

By following this systematic approach, clinicians can effectively interpret PFTs to aid in diagnosis, assess disease severity, monitor disease progression, and evaluate response to treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Respiratory Conditions and Pulmonary Function Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.